New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PTC Therapeutics, Inc.
PTCT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4B

Biotechnology

Next Earning date - 24 Apr 2025

4B

Biotechnology

Next Earning date - 24 Apr 2025

51.82USD

Shape2.15 ( 4.33%)
sun-fogPre-market 60.02$arrow-right-up8.21 (15.83%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

93
favorite-chart

Volume Buzz

8%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated March 11, 2025
1W 1.08 % 1M 7.28 % 3M 10.83 % 1Y 65.64 %

Key Metrics

Shape
  • Market Cap

    4.14B


  • Shares Outstanding

    78.87M


  • Share in Float

    76.80M


  • Dividende

    0


  • Earning Date

    24 Apr 2025


  • Price Target

    52.49


  • Average Volume

    709315


  • Beta

    0.66


  • Range

    23.995-55.6


  • Industry

    Biotechnology


  • Website

    https://www.ptcbio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

PTCT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$732M

Shape243%

2025-Revenue

$2.73

Shape-217%

2025-EPS

$366M

Shape-682%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

58.00(10.50%)

Number of analyst

1

Last analyst upgrade/downgrade

Scotiabank

initialise

Previous: Not converted

2025-03-07

Now: Sector Perform

UBS

upgrade

Previous: Not converted

2024-08-26

Now: Buy

Raymond James

upgrade

Previous: Underperform

2024-05-20

Now: Market Perform

Goldman Sachs

initialise

Previous: Not converted

2022-12-14

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-1.88
vs -1.78

Q2.23

arrow
arrow

N/A

-2.66
vs -2.13

Q3.23

arrow
arrow

N/A

-1.76
vs -1.53

Q4.23

arrow
arrow

N/A

-0.24
vs -2.35

Q1.24

arrow
arrow

N/A

-1.20
vs -1.88

Q2.24

arrow
arrow

N/A

-1.16
vs -2.66

Q3.24

arrow
arrow

N/A

-1.39
vs -1.76

Q4.24

arrow
arrow

N/A

-0.24
vs -0.24

Q1.25

arrow
arrow

N/A

-1.03
vs -1.20

Q2.25

arrow
arrow

N/A

-1.04
vs -1.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+48%

220.4M  vs 148.7M

Q2.23

arrow
arrow

+29%

213.8M  vs 165.5M

Q3.23

arrow
arrow

-9%

196.6M  vs 217.1M

Q4.23

arrow
arrow

+83%

307.1M  vs 167.4M

Q1.24

arrow
arrow

-5%

210.1M  vs 220.4M

Q2.24

arrow
arrow

-13%

186.7M  vs 213.8M

Q3.24

arrow
arrow

+0%

196.8M  vs 196.6M

Q4.24

arrow
arrow

-31%

213.2M  vs 307.1M

Q1.25

arrow
arrow

-20%

168.6M  vs 210.1M

Q2.25

arrow
arrow

-10%

168.3M  vs 186.7M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+30%

0.3
vs 0.49

Q2.23

arrow
arrow

+34%

0.34
vs 0.3

Q3.23

arrow
arrow

+20%

0.2
vs 0.34

Q4.23

arrow
arrow

+19%

0.19
vs 0.2

Q1.24

arrow
arrow

+10%

0.1
vs 0.19

Q2.24

arrow
arrow

+10%

0.1
vs 0.1

Q3.24

arrow
arrow

+10%

0.1
vs 0.1

Q4.24

arrow
arrow

+6%

0.06
vs 0.1

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

215

215
vs 213

1%

Q2.23

arrow
arrow

213

213
vs 215

-1%

Q3.23

arrow
arrow

187

187
vs 213

-12%

Q4.23

arrow
arrow

180

180
vs 187

-4%

Q1.24

arrow
arrow

192

192
vs 180

7%

Q2.24

arrow
arrow

204

204
vs 192

6%

Q3.24

arrow
arrow

211

211
vs 204

3%

Q4.24

arrow
arrow

246

246
vs 211

17%

Earnings Growth

Latest News